Investigators tested a new neoadjuvant immunotherapy to fight prostate cancer using a virus-mimicking drug to activate the immune system.

A national clinical trial led by the Alliance for Clinical Trials in Oncology has found that oxybutynin, a drug often used to ...

The MarketWatch News Department was not involved in the creation of this content. St Bartholomew's Hospital and The James Cook University Hospital mark key UK expansion of the company's Phase 2 mCRPC ...

The Alliance for Clinical Trials in Oncology has launched a randomized phase III clinical trial called RECIPROCAL (Alliance A032304) to explore whether doctors can optimize the timing of targeted ...

A personalized cancer treatment developed by Moderna Inc. and Merck & Co. helped prevent the recurrence of high-risk skin cancer after five years, new data confirming its prolonged benefit show.

KAIST researchers have developed a way to reprogram immune cells already inside tumors into cancer-killing machines. A drug injected directly into the tumor is absorbed by macrophages, prompting them ...

With two seconds left on the clock, the Baltimore Ravens put their season in a rookie's hands. Kicker Tyler Loop trotted out to the field looking to send his team to the postseason with a 44-yard ...

The Ravens' season ended in the cruelest of ways Sunday night after rookie kicker Tyler Loop missed a 44-yard field goal that sealed their Week 18 loss to the Steelers as well as their playoff fate.

Hydrogels are among the most widely studied biomaterials in modern drug delivery research. Their high hydrophilicity, ...